本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Phathom Pharmaceuticals

12.02
0.0000
盤後12.01-0.0099-0.08%19:20 EST
成交量:69.86萬
成交額:850.00萬
市值:9.41億
市盈率:-3.16
高:12.50
開:12.20
低:11.95
收:12.02
52周最高:18.31
52周最低:2.21
股本:7,829.48萬
流通股本:5,756.69萬
量比:0.98
換手率:1.21%
股息:- -
股息率:- -
每股收益(TTM):-3.8010
每股收益(LYR):-5.2920
淨資產收益率:-3489.00%
總資產收益率:-42.54%
市淨率:-2.23
市盈率(LYR):-2.27

資料載入中...

公司資料

公司名字:
Phathom Pharmaceuticals
交易所:
NASDAQ
成立時間:
2018
員工人數:
427
公司地址:
100 Campus Drive,Suite 102,Florham Park,New Jersey,United States
郵編:
07932
電話:
傳真:
- -
簡介:
Phathom Pharmaceuticals, Inc.於2018年1月9日根據特拉華州法律註冊成立。該公司是一家生物製藥公司,專註於開發和商業化治療胃腸道疾病或GI疾病的新療法。

董事

名稱
職位
Michael F. Cola
Director and Chairman
Steven Basta
President, Chief Executive Officer and Director
Asit Parikh
Director
Frank Karbe
Director
Heidi Kunz
Director
James Topper
Director
Mark Stenhouse
Director
Theodore R. Schroeder
Director

股東

名稱
職位
Steven Basta
President, Chief Executive Officer and Director
Azmi Nabulsi
Chief Operating Officer
Molly Henderson
Chief Financial and Business Officer
Robert Breedlove
Principal Accounting Officer
Sanjeev Narula
Chief Financial and Business Officer and Principal Financial Officer